209 related articles for article (PubMed ID: 1510369)
1. Mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson's Disease Research Group.
Schapira AH; Mann VM; Cooper JM; Krige D; Jenner PJ; Marsden CD
Ann Neurol; 1992; 32 Suppl():S116-24. PubMed ID: 1510369
[TBL] [Abstract][Full Text] [Related]
2. Iron-dependent enzymes in Parkinson's disease.
Reichmann H; Janetzky B; Riederer P
J Neural Transm Suppl; 1995; 46():157-64. PubMed ID: 8821051
[TBL] [Abstract][Full Text] [Related]
3. Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease.
Ebadi M; Govitrapong P; Sharma S; Muralikrishnan D; Shavali S; Pellett L; Schafer R; Albano C; Eken J
Biol Signals Recept; 2001; 10(3-4):224-53. PubMed ID: 11351130
[TBL] [Abstract][Full Text] [Related]
4. Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal.
Schapira AH
Mov Disord; 1994 Mar; 9(2):125-38. PubMed ID: 8196673
[TBL] [Abstract][Full Text] [Related]
5. Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease.
Schapira AH; Mann VM; Cooper JM; Dexter D; Daniel SE; Jenner P; Clark JB; Marsden CD
J Neurochem; 1990 Dec; 55(6):2142-5. PubMed ID: 2121905
[TBL] [Abstract][Full Text] [Related]
6. Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease.
Mann VM; Cooper JM; Krige D; Daniel SE; Schapira AH; Marsden CD
Brain; 1992 Apr; 115 ( Pt 2)():333-42. PubMed ID: 1606472
[TBL] [Abstract][Full Text] [Related]
7. Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group.
Krige D; Carroll MT; Cooper JM; Marsden CD; Schapira AH
Ann Neurol; 1992 Dec; 32(6):782-8. PubMed ID: 1471869
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases.
Gu M; Owen AD; Toffa SE; Cooper JM; Dexter DT; Jenner P; Marsden CD; Schapira AH
J Neurol Sci; 1998 Jun; 158(1):24-9. PubMed ID: 9667773
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial complex I deficiency in Parkinson's disease.
Schapira AH
Adv Neurol; 1993; 60():288-91. PubMed ID: 8420145
[No Abstract] [Full Text] [Related]
10. Mitochondrial DNA and Parkinson's disease.
Di Monte DA
Neurology; 1991 May; 41(5 Suppl 2):38-42; discussion 42-3. PubMed ID: 1904141
[TBL] [Abstract][Full Text] [Related]
11. Role of mitochondria in the etiology and pathogenesis of Parkinson's disease.
Mizuno Y; Ikebe S; Hattori N; Nakagawa-Hattori Y; Mochizuki H; Tanaka M; Ozawa T
Biochim Biophys Acta; 1995 May; 1271(1):265-74. PubMed ID: 7599219
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial complex I deficiency in Parkinson's disease.
Schapira AH; Cooper JM; Dexter D; Clark JB; Jenner P; Marsden CD
J Neurochem; 1990 Mar; 54(3):823-7. PubMed ID: 2154550
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria in the etiology and pathogenesis of Parkinson's disease.
Schapira AH; Gu M; Taanman JW; Tabrizi SJ; Seaton T; Cleeter M; Cooper JM
Ann Neurol; 1998 Sep; 44(3 Suppl 1):S89-98. PubMed ID: 9749579
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
15. No evidence for altered muscle mitochondrial function in Parkinson's disease.
Anderson JJ; Bravi D; Ferrari R; Davis TL; Baronti F; Chase TN; Dagani F
J Neurol Neurosurg Psychiatry; 1993 May; 56(5):477-80. PubMed ID: 8505638
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group.
Jenner P; Dexter DT; Sian J; Schapira AH; Marsden CD
Ann Neurol; 1992; 32 Suppl():S82-7. PubMed ID: 1510385
[TBL] [Abstract][Full Text] [Related]
17. Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage.
Flønes IH; Fernandez-Vizarra E; Lykouri M; Brakedal B; Skeie GO; Miletic H; Lilleng PK; Alves G; Tysnes OB; Haugarvoll K; Dölle C; Zeviani M; Tzoulis C
Acta Neuropathol; 2018 Mar; 135(3):409-425. PubMed ID: 29270838
[TBL] [Abstract][Full Text] [Related]
18. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
19. Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis.
Beal MF
Ann Neurol; 1998 Sep; 44(3 Suppl 1):S110-4. PubMed ID: 9749581
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial DNA analysis in Parkinson's disease.
Schapira AH; Holt IJ; Sweeney M; Harding AE; Jenner P; Marsden CD
Mov Disord; 1990; 5(4):294-7. PubMed ID: 1979656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
